| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K04800985 |
| PharmacoGx | BRD-K04800985 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SLC6A2 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | MAX | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-08 |
| mRNA | MEX3B | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-09 |
| mRNA | SLC1A7 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-11 |
| mRNA | NODAL | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-11 |
| mRNA | SYNPO2 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-09 |
| mRNA | EGLN3 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-09 |
| mRNA | HID1 | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-10 |
| mRNA | FAM163A | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0003 |
| mRNA | PHOX2A | CTRPv2 | pan-cancer | AAC | 0.37 | 4e-05 |
